Every past email, newest first.
The week's news on peptides and GLP-1s, with the document behind each line and a link to the full article.
Get the next onePeptide shot triggered a death, coroner says
Plus: retatrutide beat Ozempic but more people quit, and 1 in 71 on a GLP-1 had trouble under anaesthesia.
A vial sold as retatrutide held none of it
Plus 234 reports on suspected fake semaglutide, and an FDA peptide plan nobody outside can read.
The pill, the fake orders, the forged lab report
A warning in Mounjaro's own leaflet, vials sold as 99% pure that tested far lower, and a prosecutors' memo.
The Wednesday email
Every Wednesday: the week's new articles, cut to the lines that matter, in about two minutes.